Question Bank › Their own money is on the line

Their own money is on the line

Their own money is on the line: management ties the company's near-term promises to consequences it will personally bear

Calls Tested
495
Answered YES
0
Hit Rate
0%
rare by design

Autodesk, Inc. (ADSK) — this company's answers

NO on the Q3 2019 call 2018-11-20 A
The model's full reasoning — Q3 2019 call → NOThe question asks whether management makes a specific forward claim about the company's own business and attaches a real consequence to themselves or the company if that claim proves wrong. Looking at the transcript, I need to find: 1. A specific, near-dated forward claim about the business 2. A self-imposed cost of being wrong, already attached Let me scan through the call for such statements. Scott Herren discusses guidance for Q4 and full-year fiscal 2019, raising outlook on key metrics. He mentions fiscal 2020 targets including $1.35 billion in free cash flow. He says "we believe we can achieve our goal of 1.35 billion in free cash flow for the year" regarding fiscal 2020. Andrew Anagnost mentions "We look forward to nearly doubling that in the next few years" regarding the sum of revenue growth and free cash flow margin. Scott Herren says "we expect a sizable uptick in cash flow in Q4" and discusses the fiscal 2020 free cash flow target of $1.35 billion. The question is whether management attaches a real consequence to these claims. Let me look for any self-imposed cost. Looking at the discussion of PlanGrid acquisition - Scott says "The transaction and associated financing costs will have some dilutive effect on our cash flow, but we believe we can achieve our goal of 1.35 billion in free cash flow for the year." This is a commitment to a target, but is there a stake attached? The guidance provided is standard forward-looking statements. The $1.35 billion free cash flow target for fiscal 2020 was previously stated at Investor Day. Management is reiterating it. Is there any personal stake, stock purchase, or committed resources tied to this specific claim? I don't see management saying they've staked anything specific on this. The buyback is described as routine capital allocation ("We continue to be committed to managing dilution and reducing shares outstanding over time"). The forward claims are standard guidance - revenue, ARR, ARPS, billings, earnings for Q4 and full year. These are ordinary business guidance without personal or committed exposure attached. The fiscal 2020 free cash flow target of $1.35 billion is a commitment, but management doesn't attach a specific cost to being wrong about it.

← Back to the full ADSK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management make a SPECIFIC FORWARD CLAIM ABOUT THE COMPANY'S OWN BUSINESS and, in the same breath, attach a REAL CONSEQUENCE TO THEMSELVES OR THE COMPANY IF THAT CLAIM PROVES WRONG — that is, do the people running the company voluntarily put something at stake behind what they are telling investors, rather than simply asserting it? Answer YES when management's own words on this call convey, in whatever form fits the business, ONE coherent posture: a forward claim that management has deliberately made costly to be wrong about. BOTH elements below must come through in management's own voice. (1) A SPECIFIC, NEAR-DATED FORWARD CLAIM ABOUT THE BUSINESS. Management states something concrete it says the company will do or achieve, specific enough that an observer could later tell whether it happened, and near enough that the answer will be known within roughly the coming year. The claim may take whatever form fits the industry — a level of output, volume, customers, sites, deliveries, or activity the company will reach; a facility, product, program, or ramp that will be operating by a stated time; a business or unit that will reach self-funding, breakeven, or a stated scale; a cost, capability, or capacity position the company will hold; a specific milestone the company will complete. Vague direction ("continued strong growth," "significant improvement") does not qualify; the claim must be checkable. (2) A SELF-IMPOSED COST OF BEING WRONG, ALREADY ATTACHED. Management, in the same discussion, points to something real that has already been committed, staked, or accepted such that management or the company visibly loses if the claim fails. Any genuine expression counts, and the form varies widely: management or insiders describing their own purchases of the company's stock, their concentrated ownership, or pay, incentives, or vesting they say are tied to this specific outcome; management describing resources it has ALREADY irreversibly committed against the claim — money spent, capacity built, inventory or long-lead items bought, people hired, obligations signed, capital deployed — such that the company is exposed if the claimed business does not arrive; management inviting investors to hold it to the number, saying to judge them on it, offering to be measured against it, or noting it is repeating a commitment it previously made and met; management staking its credibility explicitly by contrasting this claim with what it said before and what it delivered; or management declining to hedge when analysts offer it an escape route, restating the commitment instead of softening it. The essence is ONE phenomenon: an operating team converting a forward statement from cheap talk into a costly signal by fastening real consequences to it. It must be evident in how management actually speaks on this call — the claim and the stake connected to each other — not assembled from unrelated remarks. Answer NO if management's forward statements are ordinary guidance, outlook, or ambition delivered without any personal or committed exposure attached — that is the normal posture, not this phenomenon. NO if the forward claim is vague, undated, or so distant that nobody will know for years. NO if the "stake" is generic alignment boilerplate ("we are shareholders too," "aligned with our owners," "management is incentivized for long-term value") with nothing specific it rides on. NO if a buyback, dividend, or compensation plan is described as routine capital allocation or standard practice, unconnected to any particular claim. NO if the committed resources are ordinary course-of-business spending that would have happened regardless of the claim. NO if management is chiefly hedging, walking back prior commitments, widening ranges, withdrawing forecasts, or explaining why earlier promises were missed. NO if the exposure is only intended, contemplated, or conditional rather than already in place. NO if the claim or the stake appears only in an analyst's question, flattery, or characterization that management does not itself adopt. Use only the supplied transcript. Answer only YES or NO.

No call in the tested sample answered YES — this hypothesis came up empty, which is itself a result.

How the model reasoned

WD · Q2 2022 → NOWe need answer YES/NO. Need analyze transcript for specific forward claim with self-imposed cost. Need be strict. We need identify if management makes specific forward claim about company's own business and attaches real consequence if wrong. Let's parse. Management gives guidance: adjusted EPS growth flat to up 10%, operating margin 24-27%, ROE 15-18%. That's ordinary guidance. They also mention buybacks, dividends. They mention "Drive to '25" goals, but long-term. They mention "we expect strong GSE origination volumes for rest of year." They mention "we are confident that we will still achieve our goal of double-digit growth in adjusted EBITDA." That's a forward claim but no self-imposed cost attached? They don't say "we stake our compensation" etc. They mention "we used $11.1 million to repurchase shares" but that's past, not tied to specific claim. They mention "we expect to continue buying back shares" but not tied to claim. Need see if management says "we will achieve" and "we are confident" but no cost. They might mention "we have taken steps to ensure we have a successful year under any scenario." No specific stake. Question asks: "On this call, does management make a SPECIFIC FORWARD CLAIM ABOUT THE COMPANY'S OWN BUSINESS and, in the same breath, attach a REAL CONSEQUENCE TO THEMSELVES OR THE COMPANY IF THAT CLAIM PROVES WRONG — that is, do the people running the company voluntarily put something at stake behind what they are telling investors, rather than simply asserting it?" Need answer YES only if both elements. Let's examine all forward claims. - "We expect our agency lending volumes to pick up in the second half of 2022 as HUD lending picks up and the GSEs deployed their $92 billion of remaining lending capacity." That's a forecast, no stake. - "We are confident that we will still achieve our goal of double-digit growth in adjusted EBITDA." That's a claim but no cost attached. They don't say "if we don't, we'll..." They don't tie compensation. - "We expect to continue buying back shares over the remainder of the year as it represents an attractive use of capital when our stock is undervalued." That's a plan, no specific claim. - "We are adjusting our guidance for 2022 ... diluted EPS growth flat to up 10%, operating margin 24-27%, ROE 15-18%." That's guidance, ordinary. - "We set a goal to grow debt financing volumes to $65 billion by 2025...
PTN · Q4 2023 → NOThe question asks whether management makes a specific forward claim about the company's own business and attaches a real consequence to themselves or the company if that claim proves wrong. Let me analyze the transcript carefully. Key forward claims made by management: 1. Vyleesi growth - "six consecutive quarters of double-digit growth" - this is past performance, not forward 2. PL9643 MELODY-1 Phase III study in dry eye disease - "completed patient enrollment" and "working to deliver top line data before calendar year-end" 3. PL8177 ulcerative colitis - "on track to complete patient enrollment by calendar year-end with the interim assessment data as early as calendar year-end" 4. BREAKOUT - "on track for top line data in the first quarter of 2024" 5. Erectile dysfunction program - "planning to initiate clinical programs as early as the end of this year" 6. Vyleesi re-licensing - "we do expect that there will be a transaction that we will strongly consider later this year" Now, do any of these have a self-imposed cost attached? Let me look for any expression where management puts something at stake: - Steve Wills talks about Vyleesi: "we're not losing any money. In fact, we're making money on Vyleesi." - this is about current state, not a forward claim with a stake. - On the Vyleesi transaction: "we do expect that there will be a transaction that we will strongly consider later this year" - this is a forward claim but vague ("strongly consider" is not a commitment). - On dry eye data: "we are working to deliver top line data before calendar year-end" - this is a forward claim but no stake attached. - On the ED program: "planning to initiate clinical programs as early as the end of this year" - again, no stake. - Steve Wills mentions: "we have multiple shots on the goal for cash flow coming in 100% separate than a potential equity raise" - this is about having options, not a specific claim with a stake. - Carl Spana says: "we certainly believe we're undervalued, and we certainly are going to be working hard to correct that" - this is vague. Is there any point where management says something like "we've already committed X resources" or "we've put our own money in" or "judge us on this"? Looking at the discussion about the ED program: "We have previously conducted clinical trials showing the synergistic effects" - this is past work, not a forward commitment.
SNAP · Q2 2022 → NOWe need answer YES/NO. Need analyze transcript. Need determine if management makes specific forward claim about company's own business and attaches real consequence if wrong. Need only transcript. We need parse call. Management includes Derek Andersen CFO, Jeremi Gorman CBO, Evan not speaking? Q&A. They discuss guidance? They gave Q3 revenue roughly flat? In letter? On call, Derek says "we believe most prudent approach... focus on providing transparency on how our business is performing right now and our plans..." They didn't give specific numeric guidance? They mention "as we enter Q3, a lot of headwinds... not clear how evolve." They mention "approximately flat growth currently." But is that a forward claim? They say "we have seen deceleration... nearly flat or approximately flat growth currently." Not necessarily commitment. Question asks: Does management make SPECIFIC FORWARD CLAIM ABOUT COMPANY'S OWN BUSINESS and in same breath attach REAL CONSEQUENCE? Need identify if any forward claim with stake. They discuss priorities: investing in DR, measurement, etc. No specific near-term target. They mention "we intend to substantially slow our rate of hiring to effectively pause growth in headcount" and "we'll be looking at rate of operating expense growth... objective to carve out path to free cash flow breakeven or better even at reduced rates of top line growth." Is that a forward claim? It's a plan, not specific checkable? "intend to substantially slow hiring" vague. No consequence attached. They mention "we may incur transition costs... expect to emerge with more focused cost structure." No stake. They mention "Snapchat+ launched" maybe not forward. Need answer NO likely. But let's thoroughly examine for any "costly signal" like management buying stock? No. They don't mention buybacks. They don't mention personal stakes. They don't invite to hold them to number. They actually avoid guidance. They say "we believe most prudent approach... focus on transparency on how business is performing right now" not forward. They don't give Q3 guidance except "roughly flattish" in letter? On call, Derek says "as we enter Q3... headwinds continue... not clear how evolve." They don't commit. Need answer NO. But let's ensure no specific claim like "we will invest heavily in DR" with committed resources? They say "we are focused on 3 priorities... investing in products...

More from the question bank

Loaded but unspentCommitment step-up grounded in demand alreadSecure base, several live doorsRoom to raise the ceilingConviction backed by things in handManagement is planning the next period arounAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.